Adalimumab in JIA-associated Uveitis Stopping Trial

Key facts

Sponsor

Nisha Acharya

Principal Investigator

Nisha Acharya, MD MS

Principal Investigator

Intervention

Adalimumab(biological)

Enrollment

87 enrolled

Eligibility

2 years · All sexes

Timeline

2020 – 2025

Study locations (21)

• University of California, Davis, Sacramento, California, United States
• University of California, San Francisco, San Francisco, California, United States
• University of Colorado Denver, Aurora, Colorado, United States
• Colorado Retina Associates, Lakewood, Colorado, United States
• University of Miami, Miami, Florida, United States
• Children's Mercy Hospital, Kansas City, Missouri, United States
• Cincinnati Children's Hospital, Cincinnati, Ohio, United States
• Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
• Vanderbilt University Medical Center, Nashville, Tennessee, United States
• University of Texas, Austin, Austin, Texas, United States
• University of Utah Health, Salt Lake City, Utah, United States
• Murdoch Children's Research Institute, Parkville, Victoria, Australia
• University Hospitals Bristol and Weston, Bristol, United Kingdom
• Cambridge University Hospital, Cambridge, United Kingdom
• University Hospitals, Leicester, Leicester, United Kingdom
• +6 more locations on ClinicalTrials.gov

Collaborators

Children's Hospital of Philadelphia · Children's Hospital Medical Center, Cincinnati · Children's Mercy Hospital Kansas City · National Eye Institute (NEI) · Great Ormond Street Hospital for Children NHS Foundation Trust · University Hospitals Bristol and Weston NHS Foundation Trust · Alder Hey Children's NHS Foundation Trust · Newcastle-upon-Tyne Hospitals NHS Trust · Sheffield Children's NHS Foundation Trust · Cambridge University Hospitals NHS Foundation Trust · Royal Children's Hospital · Norfolk and Norwich University Hospitals NHS Foundation Trust · Vanderbilt University Medical Center · University of California, Davis · University of Texas at Austin · University of Miami · University Hospitals, Leicester · University of Utah · Colorado Retina Associates · Manchester University NHS Foundation Trust

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Anterior uveitis

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07285070
  Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
  Novaliq GmbH
• RECRUITINGPHASE2NCT07552012
  A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU
  Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07218770
  A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
  Regeneron Pharmaceuticals
• ACTIVE NOT RECRUITINGNANCT07262437
  Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles
  University of Milan
• ACTIVE NOT RECRUITINGPHASE3NCT06431373
  A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
  Priovant Therapeutics, Inc.
• RECRUITINGNCT07065747
  Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
  Oregon Health and Science University
• RECRUITINGNCT06720376
  Observational Prospective Turkish Inception Cohort of Uveitis and Spondyloarthritis
  Marmara University
• RECRUITINGPHASE3NCT05486468
  The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
  Texas Retina Associates

See all trials for Anterior uveitis →